Home > Products > Antibodies > Biosimilars

Research Grade Vadastuximab (HB185036)

Price(USD): $
Spec:
  • 100ug
  • 1mg
Number:
Contact us
  • Overview
  • Images
  • References
  • Datasheet
Overview
Catalog No.HB185036
Species reactivityHuman
ApplicationsResearch Grade Biosimilar
Host speciesChimeric
IsotypeIgG1-kappa
Expression systemMammalian Cells
ClonalityMonoclonal
TargetMyeloid cell surface antigen CD33, Sialic acid-binding Ig-like lectin 3, Siglec-3, CD33, gp67, SIGLEC3
Endotoxin levelPlease contact the lab for this information.
Purity>95% purity as determined by SDS-PAGE.
PurificationProtein A/G, purified from cell culture supernatant.
AccessionP20138
FormLiquid
Storage buffer0.01M PBS,pH7.4.
Stability and StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate NamesSGN-CD33A,h2H12ec-SGD-1910,h2H12ec-mc-val-ala-SGD-1882,CAS:1436390-63-4
BackgroundVadastuximab is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine.
NoteFor research use only. Not for use in clinical or therapeutic applications.
Images
  • Bioactivity

    Detects Recombinant Human CD33 Protein, C-His (Cat No.: HB185011) in indirect ELISA.

References

Recommendation